|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2011. View Article : Google Scholar
|
|
2
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Japan Society of Gynecologic Oncology
(eds), . Formulation Committee of the Treatment Guidelines for
Cervical Cancer, 2011. Kanehara & Co.; Tokyo: 2011, (In
Japanese).
|
|
4
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer
Version II. 2013.simplehttps://www2.tri-kobe.org/nccn/guideline/gynecological/english/cervical.pdf
|
|
5
|
Morris M, Eifel PJ, Lu J, Grigsby PW,
Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG:
Pelvic radiation with concurrent chemotherapy compared with pelvic
and para-aortic radiation for high-risk cervical cancer. N Engl J
Med. 340:1137–1143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eifel PJ, Winter K, Morris M, Levenback C,
Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic
irradiation with concurrent chemotherapy versus pelvic and
para-aortic irradiation for high-risk cervical cancer: An update of
radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol.
22:872–880. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishiko O, Sumi T, Yasui T, Matsumoto Y,
Kawamura N, Ogita S, Kamino T, Nakamura K and Yamada R:
Balloon-occluded arterial infusion chemotherapy, simple total
hysterectomy and radiotherapy as a useful combination-therapy for
advanced cancer of the uterine cervix. Oncol Rep. 7:141–144.
2000.PubMed/NCBI
|
|
8
|
Souhami L, Gil RA, Allan SE, Canary PC,
Araújo CM, Pinto LH and Silveira TR: A randomized trial of
chemotherapy followed by pelvic radiation therapy in stage IIIB
carcinoma of the cervix. J Clin Oncol. 9:970–977. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tattersall MH, Lorvidhaya V, Vootiprux V,
Cheirsilpa A, Wong F, Azhar T, Lee HP, Kang SB, Manalo A, Yen MS,
et al: Randomized trial of epirubicin and cisplatin chemotherapy
followed by pelvic radiation in locally advanced cervical cancer.
Cervical cancer study group of the asian oceanian clinical oncology
association. J Clin Oncol. 13:444–451. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishiko O, Sumi T, Yasui T, Matsumoto Y,
Ogita S, Kaminou T, Nakamura K and Yamada R: Tumor marker and MR
imaging criteria for evaluating the efficacy of cyclic
balloon-occluded arterial infusion for advanced cancer of the
uterine cervix. Oncol Rep. 7:827–830. 2000.PubMed/NCBI
|
|
11
|
Ishiko O, Sumi T, Yoshida H, Ogita S and
Yamada R: Expression of apoptosis regulatory proteins in advanced
cancer of the uterine cervix after cyclic balloon-occluded arterial
infusion chemotherapy. Int J Oncol. 18:1151–1155. 2001.PubMed/NCBI
|
|
12
|
Okamoto E, Sumi T, Misugi F, Nobeyama H,
Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K and Ishiko O:
Expression of apoptosis-related proteins in advanced uterine
cervical cancer after balloon-occluded arterial infusion
chemotherapy as an indicator of the efficiency of this therapy. Int
J Mol Med. 15:41–47. 2005.PubMed/NCBI
|
|
13
|
Nobeyama H, Sumi T, Misugi F, Okamoto E,
Hattori K, Matsumoto Y, Yasui T, Honda K, Iwai K and Ishiko O:
Association of HPV infection with prognosis after neoadjuvant
chemotherapy in advanced uterine cervical cancer. Int J Mol Med.
14:101–105. 2004.PubMed/NCBI
|
|
14
|
Benedetti Panici P, Bellati F, Manci N,
Pernice M, Plotti F, Di Donato V, Calcagno M, Zullo MA, Muzii L and
Angioli R: Neoadjuvant chemotherapy followed by radical surgery in
patients affected by FIGO stage IVA cervical cancer. Ann Surg
Oncol. 14:2643–2648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siddik ZH: Cisplatin: Mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Q, Shi S, He W, Padilla MT, Zhang L,
Wang X, Zhang B and Lin Y: Retaining MKP1 expression and
attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance
through miR-940 inhibition. Oncotarget. 5:1304–1314. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bedford MT and Richard S: Arginine
methylation an emerging regulator of protein function. Mol Cell.
18:263–72. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baldwin RM, Morettin A and Côté J: Role of
PRMTs in cancer: Could minor isoforms be leaving a mark? World J
Biol Chem. 5:115–129. 2014.PubMed/NCBI
|
|
19
|
Hirata Y, Katagiri K, Nagaoka K, Morishita
T, Kudoh Y, Hatta T, Naguro I, Kano K, Udagawa T, Natsume T, et al:
TRIM48 promotes ASK1 activation and cell death through
ubiquitination-dependent degradation of the ASK1-negative regulator
PRMT1. Cell Rep. 21:2447–2457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao HW, Hsu JM, Xia W, Wang HL, Wang YN,
Chang WC, Arold ST, Chou CK, Tsou PH, Yamaguchi H, et al:
PRMT1-mediated methylation of the EGF receptor regulates signaling
and cetuximab response. J Clin Invest. 125:4529–4543. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Lu Q, Li C, Wang X, Jiang L, Huang
L, Wang C and Chen H: PRMT1 regulates the tumour-initiating
properties of esophageal squamous cell carcinoma through histone H4
arginine methylation coupled with transcriptional activation. Cell
Death Dis. 10:3592019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsuji K, Yamada R, Kawabata M, Mitsuzane
K, Sato M, Iwahashi M, Kitayama S and Nakano R: Effect of balloon
occluded arterial infusion of anticancer drugs on the prognosis of
cervical cancer treated with radiation therapy. Int J Radiat Oncol
Biol Phys. 32:1337–1345. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sinicrope FA, Ruan SB, Cleary KR, Stephens
LC, Lee JJ and Levin B: Bcl-2 and p53 oncoprotein expression during
colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho JH, Lee MK, Yoon KW, Lee J, Cho SG and
Choi EJ: Arginine methylation-dependent regulation of ASK1
signaling by PRMT1. Cell Death Differ. 19:859–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
